ENST00000605275.1:n.209-829_209-828insTTT

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1

The ENST00000605275.1(GALT):​n.209-829_209-828insTTT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.24 ( 3972 hom., cov: 0)

Consequence

GALT
ENST00000605275.1 intron

Scores

Not classified

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.901

Publications

0 publications found
Variant links:
Genes affected
GALT (HGNC:4135): (galactose-1-phosphate uridylyltransferase) Galactose-1-phosphate uridyl transferase (GALT) catalyzes the second step of the Leloir pathway of galactose metabolism, namely the conversion of UDP-glucose + galactose-1-phosphate to glucose-1-phosphate + UDP-galactose. The absence of this enzyme results in classic galactosemia in humans and can be fatal in the newborn period if lactose is not removed from the diet. The pathophysiology of galactosemia has not been clearly defined. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
GALT Gene-Disease associations (from GenCC):
  • classic galactosemia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • galactosemia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Myriad Women’s Health

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP6
Variant 9-34645848-A-ATTT is Benign according to our data. Variant chr9-34645848-A-ATTT is described in ClinVar as [Benign]. Clinvar id is 1331424.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.302 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GALTENST00000605275.1 linkn.209-829_209-828insTTT intron_variant Intron 1 of 1 3
ENSG00000294190ENST00000721802.1 linkn.127-1235_127-1234insAAA intron_variant Intron 1 of 2

Frequencies

GnomAD3 genomes
AF:
0.241
AC:
30160
AN:
125386
Hom.:
3970
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.239
Gnomad AMI
AF:
0.245
Gnomad AMR
AF:
0.231
Gnomad ASJ
AF:
0.284
Gnomad EAS
AF:
0.0632
Gnomad SAS
AF:
0.317
Gnomad FIN
AF:
0.190
Gnomad MID
AF:
0.233
Gnomad NFE
AF:
0.253
Gnomad OTH
AF:
0.247
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.241
AC:
30157
AN:
125368
Hom.:
3972
Cov.:
0
AF XY:
0.237
AC XY:
14102
AN XY:
59420
show subpopulations
African (AFR)
AF:
0.239
AC:
7651
AN:
31974
American (AMR)
AF:
0.231
AC:
2812
AN:
12176
Ashkenazi Jewish (ASJ)
AF:
0.284
AC:
917
AN:
3226
East Asian (EAS)
AF:
0.0632
AC:
267
AN:
4226
South Asian (SAS)
AF:
0.317
AC:
1156
AN:
3650
European-Finnish (FIN)
AF:
0.190
AC:
1151
AN:
6060
Middle Eastern (MID)
AF:
0.233
AC:
55
AN:
236
European-Non Finnish (NFE)
AF:
0.253
AC:
15522
AN:
61268
Other (OTH)
AF:
0.246
AC:
419
AN:
1706
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
989
1979
2968
3958
4947
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
314
628
942
1256
1570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.160
Hom.:
247

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Dec 16, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: GALT c.-839_-837dupTTT is located in the untranscribed region upstream of the GALT gene region. The variant allele was found at a frequency of 0.24 in 124282 control chromosomes in the gnomAD v3.1.2 database, including 3940 homozygotes. The observed variant frequency is approximately 83-fold of the estimated maximal expected allele frequency for a pathogenic variant in GALT causing Galactosemia phenotype (0.0029), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.-839_-837dupTTT in individuals affected with Galactosemia and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.90

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs549043849; hg19: chr9-34645845; API